{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T14:21:13Z","timestamp":1769264473494,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T00:00:00Z","timestamp":1539302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T00:00:00Z","timestamp":1539302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Long-term estrogen deprivation (LTED) of an estrogen receptor (ER) \u03b1-positive breast cancer cell line recapitulates cancer cells that have acquired estrogen-independent cell proliferation and endocrine therapy resistance. Previously, we have shown that a cluster of non-coding RNAs, <jats:italic>Eleanors<\/jats:italic> (<jats:italic>ESR1 locus enhancing and activating non-coding RNAs<\/jats:italic>) formed RNA cloud and upregulated the <jats:italic>ESR1<\/jats:italic> gene in the nuclei of LTED cells. <jats:italic>Eleanors<\/jats:italic> were inhibited by resveratrol through ER. Here we prepared another polyphenol, glyceollin I from stressed soybeans, and identified it as a major inhibitor of the <jats:italic>Eleanor<\/jats:italic> RNA cloud and <jats:italic>ESR1<\/jats:italic> mRNA transcription. The inhibition was independent of ER, unlike one by resveratrol. This was consistent with a distinct tertiary structure of glyceollin I for ER binding. Glyceollin I preferentially inhibited the growth of LTED cells and induced apoptosis. Our results suggest that glyceollin I has a novel role in LTED cell inhibition through <jats:italic>Eleanors<\/jats:italic>. In other words, LTED cells or endocrine therapy-resistant breast cancer cells may be ready for apoptosis, which can be triggered with polyphenols both in ER-dependent and ER-independent manners.<\/jats:p>","DOI":"10.1038\/s41598-018-33227-y","type":"journal-article","created":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T14:58:26Z","timestamp":1539010706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Endocrine therapy-resistant breast cancer model cells are inhibited by soybean glyceollin I through Eleanor non-coding RNA"],"prefix":"10.1038","volume":"8","author":[{"given":"Tatsuro","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiyomi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Tachiwana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Kumabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9137-8417","authenticated-orcid":false,"given":"Toshiro","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadatoshi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Shinagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,12]]},"reference":[{"key":"33227_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrc721","volume":"2","author":"S Ali","year":"2002","unstructured":"Ali, S. & Coombes, R. C. Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer 2, 101\u2013112 (2002).","journal-title":"Nat Rev Cancer"},{"key":"33227_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1056\/NEJMra050776","volume":"354","author":"JD Yager","year":"2006","unstructured":"Yager, J. D. & Davidson, N. E. Estrogen carcinogenesis in breast cancer. N Engl J Med 354, 270\u2013282 (2006).","journal-title":"N Engl J Med"},{"key":"33227_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nrc2713","volume":"9","author":"EA Musgrove","year":"2009","unstructured":"Musgrove, E. A. & Sutherland, R. L. Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer 9, 631\u2013643 (2009).","journal-title":"Nat Rev Cancer"},{"key":"33227_CR4","first-page":"4355","volume":"47","author":"BS Katzenellenbogen","year":"1987","unstructured":"Katzenellenbogen, B. S., Kendra, K. L., Norman, M. J. & Berthois, Y. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res 47, 4355\u20134360 (1987).","journal-title":"Cancer Res"},{"key":"33227_CR5","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/0277-5379(87)90062-9","volume":"23","author":"WV Welshons","year":"1987","unstructured":"Welshons, W. V. & Jordan, V. C. Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) culture. Eur J Cancer Clin Oncol 23, 1935\u20131939 (1987).","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"Suppl 1","key":"33227_CR6","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1677\/erc.1.01018","volume":"12","author":"RJ Santen","year":"2005","unstructured":"Santen, R. J. et al. Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity. Endocr Relat Cancer 12(Suppl 1), S61\u201373 (2005).","journal-title":"Endocr Relat Cancer"},{"key":"33227_CR7","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1210\/endo.139.10.6229","volume":"139","author":"MH Jeng","year":"1998","unstructured":"Jeng, M. H. et al. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells. Endocrinology 139, 4164\u20134174 (1998).","journal-title":"Endocrinology"},{"key":"33227_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0960-0760(02)00074-2","volume":"81","author":"CM Chan","year":"2002","unstructured":"Chan, C. M., Martin, L. A., Johnston, S. R., Ali, S. & Dowsett, M. Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation. J Steroid Biochem Mol Biol 81, 333\u2013341 (2002).","journal-title":"J Steroid Biochem Mol Biol"},{"key":"33227_CR9","doi-asserted-by":"publisher","first-page":"30458","DOI":"10.1074\/jbc.M305226200","volume":"278","author":"LA Martin","year":"2003","unstructured":"Martin, L. A. et al. Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation. J Biol Chem 278, 30458\u201330468 (2003).","journal-title":"J Biol Chem"},{"key":"33227_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7966","volume":"6","author":"S Tomita","year":"2015","unstructured":"Tomita, S. et al. A cluster of noncoding RNAs activates the ESR1 locus during breast cancer adaptation. Nat Commun 6, 6966 (2015).","journal-title":"Nat Commun"},{"key":"33227_CR11","doi-asserted-by":"publisher","first-page":"14138","DOI":"10.1073\/pnas.94.25.14138","volume":"94","author":"BD Gehm","year":"1997","unstructured":"Gehm, B. D., McAndrews, J. M., Chien, P. Y. & Jameson, J. L. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 94, 14138\u201314143 (1997).","journal-title":"Proc Natl Acad Sci USA"},{"key":"33227_CR12","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1093\/jnci\/93.22.1714","volume":"93","author":"RX Song","year":"2001","unstructured":"Song, R. X. et al. Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol. J Natl Cancer Inst 93, 1714\u20131723 (2001).","journal-title":"J Natl Cancer Inst"},{"key":"33227_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10495-005-1903-2","volume":"10","author":"RX Song","year":"2005","unstructured":"Song, R. X., Zhang, Z., Mor, G. & Santen, R. J. Down-regulation of Bcl-2 enhances estrogen apoptotic action in long-term estradiol-depleted ER(+) breast cancer cells. Apoptosis 10, 667\u2013678 (2005).","journal-title":"Apoptosis"},{"key":"33227_CR14","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/bjc.2013.520","volume":"109","author":"H Iwase","year":"2013","unstructured":"Iwase, H. et al. Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a prospective study. Br J Cancer 109, 1537\u20131542 (2013).","journal-title":"Br J Cancer"},{"key":"33227_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1023\/A:1010619225209","volume":"67","author":"PE Lonning","year":"2001","unstructured":"Lonning, P. E. et al. High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy. Breast Cancer Res Treat 67, 111\u2013116 (2001).","journal-title":"Breast Cancer Res Treat"},{"key":"33227_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/bcr436","volume":"4","author":"JN Ingle","year":"2002","unstructured":"Ingle, J. N. Estrogen as therapy for breast cancer. Breast Cancer Res 4, 133\u2013136 (2002).","journal-title":"Breast Cancer Res"},{"key":"33227_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1056\/NEJM198101013040104","volume":"304","author":"JN Ingle","year":"1981","unstructured":"Ingle, J. N. et al. Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer. N Engl J Med 304, 16\u201321 (1981).","journal-title":"N Engl J Med"},{"key":"33227_CR18","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1001\/jama.2009.1204","volume":"302","author":"MJ Ellis","year":"2009","unstructured":"Ellis, M. J. et al. Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study. JAMA 302, 774\u2013780 (2009).","journal-title":"JAMA"},{"key":"33227_CR19","first-page":"1750","volume":"86","author":"ME Burow","year":"2001","unstructured":"Burow, M. E. et al. Phytochemical glyceollins, isolated from soy, mediate antihormonal effects through estrogen receptor alpha and beta. J Clin Endocrinol Metab 86, 1750\u20131758 (2001).","journal-title":"J Clin Endocrinol Metab"},{"key":"33227_CR20","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.foodres.2013.01.024","volume":"54","author":"ID Nwachukwu","year":"2013","unstructured":"Nwachukwu, I. D., Luciano, F. B. & Udenigwe, C. C. The inducible soybean glyceollin phytoalexins with multifunctional health-promoting properties. Food Research International 54, 1208\u20131216 (2013).","journal-title":"Food Research International"},{"key":"33227_CR21","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1289\/ehp.00108867","volume":"108","author":"GN Nikov","year":"2000","unstructured":"Nikov, G. N., Hopkins, N. E., Boue, S. & Alworth, W. L. Interactions of dietary estrogens with human estrogen receptors and the effect on estrogen receptor-estrogen response element complex formation. Environ Health Perspect 108, 867\u2013872 (2000).","journal-title":"Environ Health Perspect"},{"key":"33227_CR22","doi-asserted-by":"publisher","first-page":"e02057","DOI":"10.7554\/eLife.02057","volume":"3","author":"JC Nwachukwu","year":"2014","unstructured":"Nwachukwu, J. C. et al. Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network. Elife 3, e02057 (2014).","journal-title":"Elife"},{"key":"33227_CR23","doi-asserted-by":"publisher","first-page":"7159","DOI":"10.1158\/1078-0432.CCR-06-1426","volume":"12","author":"VA Salvo","year":"2006","unstructured":"Salvo, V. A. et al. Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis. Clin Cancer Res 12, 7159\u20137164 (2006).","journal-title":"Clin Cancer Res"},{"key":"33227_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1124\/jpet.109.160382","volume":"332","author":"MC Zimmermann","year":"2010","unstructured":"Zimmermann, M. C. et al. Glyceollin I, a novel antiestrogenic phytoalexin isolated from activated soy. J Pharmacol Exp Ther 332, 35\u201345 (2010).","journal-title":"J Pharmacol Exp Ther"},{"key":"33227_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3892\/ol.2011.460","volume":"3","author":"LV Rhodes","year":"2012","unstructured":"Rhodes, L. V. et al. Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer. Oncol Lett 3, 163\u2013171 (2012).","journal-title":"Oncol Lett"},{"key":"33227_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jsbmb.2014.12.014","volume":"150","author":"MR Bratton","year":"2015","unstructured":"Bratton, M. R. et al. Glyceollin, a novel regulator of mTOR\/p70S6 in estrogen receptor positive breast cancer. J Steroid Biochem Mol Biol 150, 17\u201323 (2015).","journal-title":"J Steroid Biochem Mol Biol"},{"key":"33227_CR27","doi-asserted-by":"publisher","first-page":"ijerph13010010","DOI":"10.3390\/ijerph13010010","volume":"13","author":"PP Carriere","year":"2015","unstructured":"Carriere, P. P. et al. Glyceollin I Reverses Epithelial to Mesenchymal Transition in Letrozole Resistant Breast Cancer through ZEB1. Int J Environ Res Public Health 13, ijerph13010010 (2015).","journal-title":"Int J Environ Res Public Health"},{"key":"33227_CR28","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/jcp.24813","volume":"230","author":"SH Lee","year":"2015","unstructured":"Lee, S. H., Jee, J. G., Bae, J. S., Liu, K. H. & Lee, Y. M. A group of novel HIF-1alpha inhibitors, glyceollins, blocks HIF-1alpha synthesis and decreases its stability via inhibition of the PI3K\/AKT\/mTOR pathway and Hsp90 binding. J Cell Physiol 230, 853\u2013862 (2015).","journal-title":"J Cell Physiol"},{"key":"33227_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-017-0182-1","volume":"15","author":"S Lecomte","year":"2017","unstructured":"Lecomte, S. et al. Glyceollins trigger anti-proliferative effects through estradiol-dependent and independent pathways in breast cancer cells. Cell Commun Signal 15, 26 (2017).","journal-title":"Cell Commun Signal"},{"key":"33227_CR30","doi-asserted-by":"publisher","first-page":"8657","DOI":"10.1021\/jf4020203","volume":"61","author":"S Aisyah","year":"2013","unstructured":"Aisyah, S., Gruppen, H., Madzora, B. & Vincken, J. P. Modulation of isoflavonoid composition of Rhizopus oryzae elicited soybean (Glycine max) seedlings by light and wounding. J Agric Food Chem 61, 8657\u20138667 (2013).","journal-title":"J Agric Food Chem"},{"key":"33227_CR31","doi-asserted-by":"publisher","first-page":"6748","DOI":"10.1021\/jf2010707","volume":"59","author":"R Simons","year":"2011","unstructured":"Simons, R. et al. Increasing soy isoflavonoid content and diversity by simultaneous malting and challenging by a fungus to modulate estrogenicity. J Agric Food Chem 59, 6748\u20136758 (2011).","journal-title":"J Agric Food Chem"},{"key":"33227_CR32","doi-asserted-by":"crossref","unstructured":"Tomita, S. et al. Roles of long noncoding RNAs in chromosome domains. Wiley Interdiscip Rev RNA (2016).","DOI":"10.1002\/wrna.1384"},{"key":"33227_CR33","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1021\/jm101619e","volume":"54","author":"RS Khupse","year":"2011","unstructured":"Khupse, R. S. et al. Biomimetic syntheses and antiproliferative activities of racemic, natural (\u2212), and unnnatural (+) glyceollin I. J Med Chem 54, 3506\u20133523 (2011).","journal-title":"J Med Chem"},{"key":"33227_CR34","doi-asserted-by":"publisher","first-page":"18879","DOI":"10.1073\/pnas.1115188108","volume":"108","author":"EA Ariazi","year":"2011","unstructured":"Ariazi, E. A. et al. Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time. Proc Natl Acad Sci USA 108, 18879\u201318886 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"33227_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nchembio.76","volume":"4","author":"KW Nettles","year":"2008","unstructured":"Nettles, K. W. et al. NFkappaB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses. Nat Chem Biol 4, 241\u2013247 (2008).","journal-title":"Nat Chem Biol"},{"key":"33227_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01864-y","volume":"8","author":"LA Martin","year":"2017","unstructured":"Martin, L. A. et al. Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance. Nat Commun 8, 1865 (2017).","journal-title":"Nat Commun"},{"key":"33227_CR37","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1210\/en.2008-1235","volume":"150","author":"SM Boue","year":"2009","unstructured":"Boue, S. M. et al. Identification of the potent phytoestrogen glycinol in elicited soybean (Glycine max). Endocrinology 150, 2446\u20132453 (2009).","journal-title":"Endocrinology"},{"key":"33227_CR38","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.steroids.2010.05.007","volume":"75","author":"F Payton-Stewart","year":"2010","unstructured":"Payton-Stewart, F. et al. Glyceollin I enantiomers distinctly regulate ER-mediated gene expression. Steroids 75, 870\u2013878 (2010).","journal-title":"Steroids"},{"key":"33227_CR39","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.celrep.2013.01.010","volume":"3","author":"H Mohammed","year":"2013","unstructured":"Mohammed, H. et al. Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. Cell Rep 3, 342\u2013349 (2013).","journal-title":"Cell Rep"},{"key":"33227_CR40","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/1097-0142(196205\/06)15:3<641::AID-CNCR2820150330>3.0.CO;2-9","volume":"15","author":"BJ Kennedy","year":"1962","unstructured":"Kennedy, B. J. Massive estrogen administration in premenopausal women with metastatic breast cancer. Cancer 15, 641\u2013648 (1962).","journal-title":"Cancer"},{"key":"33227_CR41","first-page":"283","volume":"16","author":"BJ Kennedy","year":"1962","unstructured":"Kennedy, B. J. Massive estrogen administration in premenopausal women with advanced breast cancer. Cancer Chemother Rep 16, 283\u2013284 (1962).","journal-title":"Cancer Chemother Rep"},{"key":"33227_CR42","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.1038\/onc.2010.333","volume":"29","author":"H Aguilar","year":"2010","unstructured":"Aguilar, H. et al. Biological reprogramming in acquired resistance to endocrine therapy of breast cancer. Oncogene 29, 6071\u20136083 (2010).","journal-title":"Oncogene"},{"key":"33227_CR43","doi-asserted-by":"publisher","first-page":"E1490","DOI":"10.1073\/pnas.1219992110","volume":"110","author":"L Magnani","year":"2013","unstructured":"Magnani, L. et al. Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer. Proc Natl Acad Sci USA 110, E1490\u20131499 (2013).","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33227-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33227-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33227-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T10:37:44Z","timestamp":1671619064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33227-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,12]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["33227"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-33227-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,12]]},"assertion":[{"value":"28 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15202"}}